Large-scale Mutational Analysis of Kv11.1 Reveals Molecular Insights into Type 2 Long QT Syndrome

Overview

Journal Nat Commun

Specialty Biology

Date 2014 Nov 25

PMID 25417810

Citations 101

Authors

Corey L Anderson

Catherine E Kuzmicki

Ryan R Childs

Caleb J Hintz

Brian P Delisle

Craig T January

Affiliations

Soon will be listed here.

Abstract

It has been suggested that deficient protein trafficking to the cell membrane is the dominant mechanism associated with type 2 Long QT syndrome (LQT2) caused by Kv11.1 potassium channel missense mutations, and that for many mutations the trafficking defect can be corrected pharmacologically. However, this inference was based on expression of a small number of Kv11.1 mutations. We performed a comprehensive analysis of 167 LQT2-linked missense mutations in four Kv11.1 structural domains and found that deficient protein trafficking is the dominant mechanism for all domains except for the distal carboxy-terminus. Also, most pore mutations--in contrast to intracellular domain mutations--were found to have severe dominant-negative effects when co-expressed with wild-type subunits. Finally, pharmacological correction of the trafficking defect in homomeric mutant channels was possible for mutations within all structural domains. However, pharmacological correction is dramatically improved for pore mutants when co-expressed with wild-type subunits to form heteromeric channels.

Citing Articles

A privileged ER compartment for post-translational heteromeric assembly of an ion channel.

Kannan S, Kasberg W, Ernandez L, Audhya A, Robertson G bioRxiv. 2025; .

PMID: 39975268 PMC: 11838338. DOI: 10.1101/2025.01.30.635714.

Integrative analysis of KCNQ1 variants reveals molecular mechanisms of type 1 long QT syndrome pathogenesis.

Brewer K, Vanoye C, Huang H, Clowes Moster K, Desai R, Hayes J Proc Natl Acad Sci U S A. 2025; 122(8):e2412971122.

PMID: 39969993 PMC: 11873829. DOI: 10.1073/pnas.2412971122.

Long-QT Trafficking Map.

London B Circulation. 2024; 150(23):1882-1884.

PMID: 39621763 PMC: 11614379. DOI: 10.1161/CIRCULATIONAHA.124.072169.

Torsades de Pointes electrical storm in children with KCNH2 mutations.

Zhang L, Xu M, Yan Z, Han Y, Jiang X, Xiao T BMC Med Genomics. 2024; 17(1):250.

PMID: 39394151 PMC: 11468024. DOI: 10.1186/s12920-024-02025-z.

Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve -LQTS Variant Classification and Cardiac Event Risk Stratification.

ONeill M, Ng C, Aizawa T, Sala L, Bains S, Winbo A Circulation. 2024; 150(23):1869-1881.

PMID: 39315434 PMC: 11611689. DOI: 10.1161/CIRCULATIONAHA.124.069828.

References

Hessa T, Meindl-Beinker N, Bernsel A, Kim H, Sato Y, Lerch-Bader M . Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature. 2007; 450(7172):1026-30. DOI: 10.1038/nature06387. View

Li L, Liu K, Hu Y, Li D, Luan S . Single mutations convert an outward K+ channel into an inward K+ channel. Proc Natl Acad Sci U S A. 2008; 105(8):2871-6. PMC: 2268552. DOI: 10.1073/pnas.0712349105. View

Huo J, Zhang Y, Huang N, Liu P, Huang C, Guo X . The G604S-hERG mutation alters the biophysical properties and exerts a dominant-negative effect on expression of hERG channels in HEK293 cells. Pflugers Arch. 2008; 456(5):917-28. DOI: 10.1007/s00424-008-0454-0. View

Johnson J, Hofman N, Haglund C, Cascino G, Wilde A, Ackerman M . Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology. 2008; 72(3):224-31. PMC: 2677528. DOI: 10.1212/01.wnl.0000335760.02995.ca. View

Al-Owais M, Bracey K, Wray D . Role of intracellular domains in the function of the herg potassium channel. Eur Biophys J. 2009; 38(5):569-76. DOI: 10.1007/s00249-009-0408-2. View

Huffaker S, Chen J, Nicodemus K, Sambataro F, Yang F, Mattay V . A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med. 2009; 15(5):509-18. PMC: 2756110. DOI: 10.1038/nm.1962. View

Gustina A, Trudeau M . A recombinant N-terminal domain fully restores deactivation gating in N-truncated and long QT syndrome mutant hERG potassium channels. Proc Natl Acad Sci U S A. 2009; 106(31):13082-7. PMC: 2722319. DOI: 10.1073/pnas.0900180106. View

Zhao J, Hill A, Varghese A, Cooper A, Swan H, Laitinen-Forsblom P . Not all hERG pore domain mutations have a severe phenotype: G584S has an inactivation gating defect with mild phenotype compared to G572S, which has a dominant negative trafficking defect and a severe phenotype. J Cardiovasc Electrophysiol. 2009; 20(8):923-30. DOI: 10.1111/j.1540-8167.2009.01468.x. View

Brelidze T, Carlson A, Zagotta W . Absence of direct cyclic nucleotide modulation of mEAG1 and hERG1 channels revealed with fluorescence and electrophysiological methods. J Biol Chem. 2009; 284(41):27989-27997. PMC: 2788851. DOI: 10.1074/jbc.M109.016337. View

10.

Shimizu W, Moss A, Wilde A, Towbin J, Ackerman M, January C . Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol. 2009; 54(22):2052-62. PMC: 2808400. DOI: 10.1016/j.jacc.2009.08.028. View

11.

Walker V, Wong M, Atanasiu R, Hantouche C, Young J, Shrier A . Hsp40 chaperones promote degradation of the HERG potassium channel. J Biol Chem. 2009; 285(5):3319-29. PMC: 2823420. DOI: 10.1074/jbc.M109.024000. View

12.

Balijepalli S, Anderson C, Lin E, January C . Rescue of mutated cardiac ion channels in inherited arrhythmia syndromes. J Cardiovasc Pharmacol. 2010; 56(2):113-22. PMC: 6287643. DOI: 10.1097/FJC.0b013e3181dab014. View

13.

Li Q, Gayen S, Chen A, Huang Q, Raida M, Kang C . NMR solution structure of the N-terminal domain of hERG and its interaction with the S4-S5 linker. Biochem Biophys Res Commun. 2010; 403(1):126-32. DOI: 10.1016/j.bbrc.2010.10.132. View

14.

Peal D, Mills R, Lynch S, Mosley J, Lim E, Ellinor P . Novel chemical suppressors of long QT syndrome identified by an in vivo functional screen. Circulation. 2010; 123(1):23-30. PMC: 3015011. DOI: 10.1161/CIRCULATIONAHA.110.003731. View

15.

Rakoczy E, Kiel C, McKeone R, Stricher F, Serrano L . Analysis of disease-linked rhodopsin mutations based on structure, function, and protein stability calculations. J Mol Biol. 2010; 405(2):584-606. DOI: 10.1016/j.jmb.2010.11.003. View

16.

Ng C, Hunter M, Perry M, Mobli M, Ke Y, Kuchel P . The N-terminal tail of hERG contains an amphipathic α-helix that regulates channel deactivation. PLoS One. 2011; 6(1):e16191. PMC: 3020963. DOI: 10.1371/journal.pone.0016191. View

17.

Muskett F, Thouta S, Thomson S, Bowen A, Stansfeld P, Mitcheson J . Mechanistic insight into human ether-à-go-go-related gene (hERG) K+ channel deactivation gating from the solution structure of the EAG domain. J Biol Chem. 2010; 286(8):6184-91. PMC: 3057830. DOI: 10.1074/jbc.M110.199364. View

18.

Sampson H, Robert R, Liao J, Matthes E, Carlile G, Hanrahan J . Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. Chem Biol. 2011; 18(2):231-42. DOI: 10.1016/j.chembiol.2010.11.016. View

19.

Gustina A, Trudeau M . hERG potassium channel gating is mediated by N- and C-terminal region interactions. J Gen Physiol. 2011; 137(3):315-25. PMC: 3047612. DOI: 10.1085/jgp.201010582. View

20.

Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A . Modelling the long QT syndrome with induced pluripotent stem cells. Nature. 2011; 471(7337):225-9. DOI: 10.1038/nature09747. View